Patients With Tumor Response (Response Evaluation Criteria in Solid Tumors) Who Received All 24 Doses of 852A. after 12 weeks (24 doses of 852A) [clinicaltrials_resource:ddfdc82818fe30b1c917d3b7a8d937ca]

Patients With Tumor Response (Response Evaluation Criteria in Solid Tumors) Who Received All 24 Doses of 852A. after 12 weeks (24 doses of 852A) [clinicaltrials_resource:ddfdc82818fe30b1c917d3b7a8d937ca]

Patients treated with at least one dose - 852A subcutaneous injection.
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:ddfdc82818fe30b1c917d3b7a8d937ca
clinicaltrials:NCT00319748
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Patients With Tumor Response (Response Evaluation Criteria in Solid Tumors) Who Received All 24 Doses of 852A. after 12 weeks (24 doses of 852A) [clinicaltrials_resource:ddfdc82818fe30b1c917d3b7a8d937ca]

Patients treated with at least one dose - 852A subcutaneous injection.
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:ddfdc82818fe30b1c917d3b7a8d937ca
Bio2RDF identifier
ddfdc82818fe30b1c917d3b7a8d937ca
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ddfdc82818fe30b1c917d3b7a8d937ca
measure [clinicaltrials_vocabulary:measure]
Patients With Tumor Response ( ...... Received All 24 Doses of 852A.
time frame [clinicaltrials_vocabulary:time-frame]
after 12 weeks (24 doses of 852A)
description
Patients treated with at least one dose - 852A subcutaneous injection.
identifier
clinicaltrials_resource:ddfdc82818fe30b1c917d3b7a8d937ca
title
Patients With Tumor Response ( ...... er 12 weeks (24 doses of 852A)
@en
inDataset
type
label
Patients With Tumor Response ( ...... dc82818fe30b1c917d3b7a8d937ca]
@en